Axogen, Inc. — Director's Dealing 2016

Oct 13, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2016-09-16

Reporting Person: Wendell Amy McBride (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-16	Stock Option (right to purchase)	$8.57	A	25000	Acquired	2023-09-16	Common Stock (25000)	Direct
2016-09-16	Stock Option (right to purchase)	$8.57	A	3750	Acquired	2023-09-16	Common Stock (3750)	Direct

Footnotes

F1: Option grant for joining the Issuer's Board of Directors. Options vest quarterly as to 12.5% of total share amount beginning with the first vesting date on December 16, 2016 and becoming fully vested September 16, 2018 (two years after grant).

F2: Annual option grant for director of Issuer's Board of Directors, pro-rated for joining Board of Directors during annual period. Option vests as to all shares December 28, 2016 in conformity with vesting for such annual director grants.